| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/26/2002 | US6350786 Complexes significantly increase the bioavailability of poorly soluble therapeutically active compounds |
| 02/26/2002 | US6350748 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350744 Pyrmidine or pyridine derivatives; antiarthritic and antiinflammatory agents; cachexia treatment; interleukin and tumor necrosis factor inhibitors |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2178302C Indole, indazole and benzisoxazole derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002014308A1 Antithrombotic agents |
| 02/21/2002 | WO2002014307A1 Factor viia inhibitors |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014274A1 Selective urokinase inhibitors |
| 02/21/2002 | WO2002014273A1 Indoline derivatives as 5ht2c antagonists |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001019791A3 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/20/2002 | EP1180513A1 Cyclic amide compounds, process for the preparation of the same and uses thereof |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336925A 4,5,6 and 7-indole and indoline derivatives, their prepn. and use |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336916A Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079396C Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 02/19/2002 | US6348628 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348482 Catechols as antimicrobial agents |
| 02/19/2002 | US6348480 Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases |
| 02/19/2002 | US6348461 Central nervous system antagonist with heterocyclic substituents |
| 02/19/2002 | US6348032 Method of inhibiting neoplastic cells with benzimidazole derivatives |
| 02/19/2002 | CA2087274C 4-alkylimidazole derivatives |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012205A1 BENZOTRIAZOLES CONTAINING α-CUMYL GROUPS SUBSTITUTED BY HETEROATOMS AND COMPOSITIONS STABILIZED THEREWITH |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 02/14/2002 | WO2001062739A3 Thioimidazolidine derivatives as light stabilizers for polymers |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019527 Antitumor, antcarcinogenic agents |
| 02/14/2002 | US20020019525 Pyrido [2,3-b] indolizine derivatives and aza analogues thereof; CRF1 specific ligands |
| 02/14/2002 | US20020019434 Indole derivatives having an antiviral activity |
| 02/14/2002 | US20020019424 1-sulfonyl pyrrolidine derivatives |
| 02/14/2002 | US20020019411 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 02/14/2002 | US20020019408 New isoxazole-sulfonamide endothelin antagonists |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020019401 Psychological disorders; adjustment of dopamine concentration |
| 02/14/2002 | US20020019390 Imidazole and imidazoline derivatives and uses thereof |
| 02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
| 02/14/2002 | US20020019383 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 02/14/2002 | CA2420967A1 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | CA2419030A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2415022A1 Cinnoline compounds |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178969A1 Gastrin and cholecystokinin receptor ligands |
| 02/13/2002 | EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
| 02/13/2002 | EP0869942B1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 02/13/2002 | EP0711768B1 Benzimidazole derivative |
| 02/13/2002 | CN1335839A Bis-sulfonamides |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335834A Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| 02/13/2002 | CN1335773A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/13/2002 | CN1079096C Arylsulfonylimidazolone derivatives as antitumor agent |
| 02/12/2002 | US6346625 Protein kinase inhibitors |
| 02/12/2002 | US6346621 Indole or quinoline compounds substituted with amino compounds on nitrogen |
| 02/12/2002 | US6346620 Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof |
| 02/12/2002 | US6346522 1-arylpyrazoles; systemic pesticides, insecticides, larvicides, miticides, antiprotozoa, and anthelmintic agents; agriculture, horticulture, animal husbandry, public health and veterinary medicine |
| 02/12/2002 | US6346503 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides |
| 02/12/2002 | CA2088742C Benzimidazole and imidazopyridine derivatives and their application |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010154A2 Substituted heterocyclic amides |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | WO2001085700A3 Hiv replication inhibiting pyrimidines and triazines |
| 02/07/2002 | WO2001062744A3 Substituted piperazine compounds |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | US20020016498 Jet streams of solvent impinge creating high turbulence at point of impact on chemical intermediates; eliminates need for high intensity milling |
| 02/07/2002 | US20020016459 Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides |
| 02/07/2002 | US20020016333 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity |
| 02/07/2002 | US20020016327 Compounds and methods of use for treatment of neurogenic inflammation |